2021 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes

Salt Lake City, UT US
October 3, 2021

This accredited continuing educational activity “2021 Precision Oncology Summit: Personalizing treatment to improve patient outcomes”, is a one-day conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies.

The goal of this activity is to improve the knowledge and competence of oncology clinicians to interpret complex molecular data and translate personalized treatment strategies into routine clinical care. The Binaytara Foundation will utilize a hybrid format (in-person and livestream) as well as recorded webcast to improve access to education.

The in-person precision oncology summit will be held on October 3, 2021 at the Hilton Salt Lake City, and a self-paced enduring component (recorded webcast) will be made available on our education portal (this website) after the meeting for one year. Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology including the key abstracts relevant to precision oncology presented at the 2021 ASCO Annual Meeting in June, 2021.

Didactic lectures, case- based presentations, and panel discussions will be used to promote leaning and to place molecular testing into clinical context and discuss how the results may effectively contribute to patient care. 

This in-person precision oncology conference will have an abstract session where new research findings in the field of precision oncology will be presented. This precision oncology conference is directed towards healthcare providers involved in care of cancer patients including medical oncologists, nurse practitioners, physician assistants, pharmacists, oncology nurses, and residents/fellows.

This 2021 Precision Oncology Summit: Personalizing treatment to improve patient outcomes conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:

  • Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options.
  • Current and evolving paradigms in precision oncology approaches for management of common malignancies.
  • Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.


All fees listed below are for licensed healthcare providers NOT EMPLOYED by an ACCME defined ineligible entity. Individuals employed by the industry must register as "industry representative" regardless of their licensure as a healthcare provider.

The registration fee below applies to participants attending only one of the two conferences being held on that weekend. If you are attending both the Precision Oncology Summit on October 3rd, 2021 & the 2021 Updates on Hematologic Malignancies on October 2nd, 2021, the fee for the second conference is $50 if registered together.

If you plan to attend both meetings, please pay the fees for both conferences together when you register for the precision oncology conference and we will enroll you in the hematology conference automatically upon receipt of the registration payment. 


Physicians - $200

Non-physician healthcare providers - $125

Residents & Fellows - $0 (see below)

Current or previous year faculties of our conferences - $0

*If you are a resident or fellow in the United States, please create a user account on this portal using your work email, and send us an email from the email address used to create the account with the name of the conference(s) that you are interested in attending, and we will register you for free. 

*If you are a resident or fellow from outside the United States, please create a user account on this portal using your work email if available, and send us an email from the email address used to create the account with the following information, and we will register you for free. 

  • Name of the conference(s) that you are interested in attending
  • A picture ID or another document showing proof of your status as Resident/Fellow/Physician in training
  • Name and email address of program director to verify your trainee status


Target Audience

  • Hematologists/Oncologists
  • Oncology Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Physician Assistants
  • Oncology Fellows/Residents
  • Oncology Nurses
  • Researchers and others involved in the care of cancer patients

Learning Objectives

Upon successful completion of this educational activity on precision oncology, participants will be able to:

  • Identify frequent molecular abnormalities across several common malignancies and understand appropriate timing of testing to detect these abnormalities.
  • Interpret results of next generation sequencing and other biomarkers predictive of response to targeted therapies and recognize the challenges involved.
  • Explain the role, including advantages and disadvantages, of different testing methodologies available for selection of targeted therapies.
  • Plan optimal molecular-targeted treatment strategies for treatment of cancer.
  • Outline emerging research, the mechanism of action, and the role of novel molecular-targeted therapies in clinical investigation for cancer patients.

    Abstract Submission Guidelines

    We will accept abstracts in the following categories. Please select a category that fits the submission best, and indicate the category in your submission email:

    • Basic Science Research
    • Clinical Research
    • Case Reports

    Notifications – Authors will be notified by August 7, 2021 via email.

    General guidelines

    Abstracts submitted should not have been previously published or presented at another meeting. Abstracts must be written in the format provided (see below).


    Abstracts should be written in English & saved as a word document or powerpoint. 
    Abstracts should be no more than 300 words (excluding abstract title, authors, and affiliations).
    If your abstract is a case report, it must include background, case discussion, and a conclusion. 
    If your abstract is a basic-science or clinical-research, it must include background, methods, results, and conclusions.
    For both primary and co-authors, credentials along with their full names and email addresses must be included. If co-authors are from different institutions, the secondary institution(s) and the institutions the authors are associated with must be listed using a superscript.
    Example:  Investigator Names:  Jane doe, MD1, Jay Jones, MD, PHD2, Danny day, MD3


    1) Hills Valley Cancer Institute,

    2) River Town Cancer Care Center,

    3) Cancer Doctors University

    Submit Abstract

    Course summary
    Course opens: 
    Course expires: 
    Event starts: 
    10/03/2021 - 7:30am
    Event ends: 
    10/03/2021 - 5:30pm

    October 3, 2021  

    (All times are listed in local Mountain Time 

    6:30 AM to 7:45 AM     


    7:45 AM to 8:00 AM
    Precision oncology in 2021 and beyond


    8:00 AM to 9:40 AM
    Session 1: Methods in Precision Oncology

    8:00 AM to 8:25 AM
    Tumor Sequencing for detection of molecular abnormalities

    8:25 AM to 8:50 AM
    Beyond Sequencing – methods in identifying tumor biomarkers for targeted therapies

    8:50 AM to 9:15 AM
    Germline genetic testing for cancer prevention and treatment

    9:15 AM to 9:40 AM
    Case-based discussion

    9:40 AM to 10:00 AM Break/Exhibits

    10:00 AM to 11:00 AM
    Session 2: Precision Oncology in Breast Cancer

    10:00 AM to 10:25 AM
    Targeted therapies in metastatic breast cancer

    10:25 AM to 10:50 AM
    Biomarker adapted strategies in locoregional management of breast cancer

    10:50 AM to 11:15 AM                     Case-based discussion

    11:15 AM to 12:15 AM
    Session 3: Precision Oncology in Lung Cancer

    11:15 AM to 11:35 AM
    Biomarker-guided therapy in metastatic lung cancer – my approach

    11:35 AM to 11:55 AM
    Targeted therapies and immunotherapy in adjuvant treatment of lung cancer

    11:55 AM to 12:15 PM
    Case-based discussions


    12:15 PM to 1:15 PM
    Lunch/Exhibits/Poster Presentations


    1:15 PM to 2:30 PM              
    Session 4: Precision Oncology in GI Malignancies

    1:15 PM to 1:40 PM
    Targeted therapies in management of metastatic and loco-regional colorectal cancer

    1:40 PM to 2:05 PM   
    Precision oncology approaches in hepatobiliary and pancreatic malignancies

    2:05 PM to 2:30 PM          
    Case-based discussion

    2:30 PM to 2:50 PM  
    Break & Exhibit

    2:50 PM to 3:40 PM
    Session 5: Precision Oncology in Prostate Cancer and Melanoma

    2:50 PM to 3:15 PM
    Precision-guided approach to management of metastatic prostate cancer

    3:15 PM to 3:40 PM
    Immunotherapy and other targeted therapies in management of melanoma

    3:40 PM to 4:05 PM                         Case-based discussion

    4:05 PM to 4:15 PM               Concluding remarks



    Hilton Salt Lake City Center, Salt Lake City, UT
    255 S W Temple
    Salt Lake City, UT 84101
    United States

    Siddhartha Yadav, MD

    Medical Oncologist

    Mayo Clinic 

    Learn More

    Sakti Chakrabarti, MD

    Associate Professor of Medicine

    Medical College of Wisconsin

    Learn More

    Benjamin Maughan, MD, PharmD

    Assistant Professor of Medicine

    Huntsman Cancer Institute, University of Utah

    Learn More

    Vivek Subbiah, MD

    Associate Professor of Medicine

    MD Anderson Cancer Center, University of Texas

    Learn More

    Narjust Duma, MD

    Assistant Professor of Medicine

    Dana-Farber Cancer Institute/Harvard University 

    Learn More

    Mark Lewis, MD

    Medical Oncologist

    Intermountain Healthcare 

    Learn More

    Christos Vaklavas, MD

    Associate Professor of Medicine

    Huntsman Cancer Institute, University of Utah

    Learn More

    Vaia Florou, MD

    Assistant Professor of Medicine

    Huntsman Cancer Institute, University of Utah

    Learn More

    Wallace Akerley, MD

    Professor of Medicine

    Huntsman Cancer Institute, University of Utah

    Learn More

    More faculty coming soon! 


    Accreditation information coming soon…


    We have exhibit and Industry Sponsored Symposia opportunities available at both of these meetings - The 2021 Updates on Hematologic Malignancies & this Precision Oncology Summit. 


    Register to exhibit at this conference here - Salt Lake City Conference Exhibit Registration

    If you would like to register to attend only, please proceed to registration and select "industry representative' for your registration type. All participants who are employed by an ACCME defined ineligible entity must register as industry representative even if they are licensed healthcare professionals.


    Please login or register to take this course.